KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $431,000 | -48.2% | 126,632 | -37.7% | 0.00% | -100.0% |
| Q2 2018 | $832,000 | 0.0% | 203,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $832,000 | -45.9% | 203,400 | -38.5% | 0.00% | -66.7% |
| Q4 2017 | $1,538,000 | +46.5% | 330,600 | +123.4% | 0.01% | +50.0% |
| Q3 2017 | $1,050,000 | -29.7% | 147,977 | -30.3% | 0.00% | -42.9% |
| Q2 2017 | $1,494,000 | +39.2% | 212,258 | +20.6% | 0.01% | +16.7% |
| Q1 2017 | $1,073,000 | -0.9% | 176,000 | -16.3% | 0.01% | +20.0% |
| Q3 2016 | $1,083,000 | -54.4% | 210,316 | -40.1% | 0.01% | -64.3% |
| Q2 2016 | $2,374,000 | – | 351,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |